Melinta Therapeutics Announces Appointment of Christine Ann Miller as President and Chief Executive Officer
August 03, 2020 08:00 ET
|
Melinta Therapeutics, Inc.
MORRISTOWN, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage company focused on the development and commercialization of novel antibiotics, today...
Cempra Announces Preliminary Results of 2017 Stockholder Vote
November 03, 2017 11:59 ET
|
Cempra, Inc.
CHAPEL HILL, N.C., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and...
Melinta and Cempra Announce Accomplished Executive Leadership Team for Combined Organization
November 01, 2017 07:00 ET
|
Cempra, Inc.; Melinta Therapeutics, Inc.
NEW HAVEN, Conn. and CHAPEL HILL, N.C., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc., a privately held company developing and commercializing novel antibiotics to treat serious...
Melinta and Cempra Name Industry Leader Daniel Wechsler as President and Chief Executive Officer of the Combined Company
October 31, 2017 07:00 ET
|
Cempra, Inc.; Melinta Therapeutics, Inc.
NEW HAVEN, Conn. and CHAPEL HILL, N.C., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc., a privately held company developing and commercializing novel antibiotics to treat serious...
Cempra and Melinta Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Merger
September 28, 2017 16:15 ET
|
Cempra, Inc.; Melinta Therapeutics
CHAPEL HILL, N.C. and NEW HAVEN, Conn., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives...
Cempra Announces Presentations at Upcoming Investor Conferences and Provides Merger Process Update
September 07, 2017 16:15 ET
|
Cempra, Inc.
CHAPEL HILL, N.C., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and...
Cempra and Melinta Announce Merger to Form Leading, Vertically Integrated Commercial-Stage Anti-Infectives Company
August 09, 2017 08:00 ET
|
Cempra, Inc.; Melinta Therapeutics
—Broad pipeline and resources provide multiple opportunities to drive long-term value creation— —Merger lays strong foundation for launch of recently FDA-approved Baxdela™ (delafloxacin)— ...
Cempra Provides Corporate Update and Reports Second Quarter 2017 Financial Results
August 09, 2017 08:00 ET
|
Cempra, Inc.
CHAPEL HILL, N.C., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and...
Cempra to Report Second Quarter 2017 Financial Results
July 20, 2017 16:05 ET
|
Cempra, Inc.
CHAPEL HILL, N.C., July 20, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and...
Eight Presentations at ASM Microbe Include Late Breaker From Cempra’s Phase 3 Fusidic Acid Study and Solithromycin Data on Gonorrhea and Otitis Media
June 02, 2017 07:15 ET
|
Cempra, Inc.
CHAPEL HILL, N.C., June 02, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...